We found that the LOXL2-interference resulted in an increase in APOBEC3A, APOBEC3B, APOBEC3D, and APOBEC3G protein levels (Figure 4E) in the cervical cancer cells. This evidence concerns the gene LOXL2 and cervical carcinoma.